Related Experiment Video
Updated: Aug 9, 2026
07:51
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
7.6K
How AI drives innovation in cardiovascular medicine
Paul L Cerrato1, John D Halamka1
1Mayo Clinic Platform, Mayo Clinic, Rochester, MN, United States.
Frontiers in Cardiovascular Medicine
|May 13, 2024
Summary
Artificial intelligence (AI) is revolutionizing patient care, particularly in cardiovascular medicine. This paper highlights key advancements in AI applications within this field.
Area of Science:
- Cardiovascular Medicine
- Artificial Intelligence
- Deep Learning
Background:
- Medicine is increasingly adopting artificial intelligence (AI) and deep learning technologies.
- These technologies are demonstrating a significant impact on patient care.
- Cardiovascular medicine is a primary area experiencing these transformative effects.
Purpose of the Study:
- To summarize significant advances in the application of AI within cardiovascular medicine.
- To provide an overview of AI's growing role in patient care in this specialty.
- To highlight key developments without conducting an exhaustive review.
Main Methods:
- This opinion paper provides a summary of existing literature and expert insights.
- It focuses on identifying and describing notable AI applications in cardiology.
- The methodology involves synthesizing information on recent progress in the domain.
Main Results:
- AI and deep learning are making measurable impacts on cardiovascular patient care.
- Several important advances have been achieved in applying AI to cardiology.
- The domain is rapidly evolving with new AI-driven solutions.
Conclusions:
- Artificial intelligence is a transformative force in modern cardiovascular medicine.
- The integration of AI promises to further enhance patient outcomes and care.
- Continued exploration and adoption of AI are crucial for the future of cardiology.
Related Concept Videos
01:27Development of the Heart
The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
01:27Regulation of the Cardiovascular System
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...